Analysis of methylation using nucleic acid arrays

US10822659B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10822659-B2
Application numberUS-201715792665-A
CountryUS
Kind codeB2
Filing dateOct 24, 2017
Priority dateMar 31, 2006
Publication dateNov 3, 2020
Grant dateNov 3, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Arrays for genome-wide analysis of methylation are disclosed. In a preferred aspect arrays comprising a plurality of probes complementary to a plurality of identified CpG islands in the human, mouse and rat genome are disclosed. The arrays may be used to detect methylation within CpG islands in samples from human, mouse and rat genomes.

First claim

Opening claim text (preview).

What is claimed is: 1. An array of probes comprising: more than 250,000 different experimental probe features, wherein (a) each experimental probe feature comprises a plurality of copies of a nucleic acid probe that is different in sequence from the probes of every other feature of the array; (b) each probe feature is at a known or determinable location in the array; and (c) at least 90% of the probe features contain full length probes that are perfectly complementary to a CpG island, wherein a CpG island is a genomic region that is at least 200 bases and has a GC content of at least 50% over its length. 2. The array of claim 1 wherein the full length probes are between 20 and 100 bases in length and are complementary to sequences in the genomes of human, mouse and rat. 3. The array of claim 1 further comprising a plurality of control features. 4. The array of claim 3 wherein the control features comprise one or more types of control features selected from the group of control feature types comprising: GC content matched anti-genomic controls, bacterial genome controls, Arabidopsis genome controls, pseudomonas genome controls; repeat region controls, 18S rRNA gene controls, 28S rRNA gene controls; and probes to one or more genes that are known to be regulated by methylation. 5. The array of claim 1 wherein each probe is between 20 and 100 bases, wherein the array comprises at least 300,000 probes and wherein at least 80% of the probes comprise at least one CG dinucleotide. 6. The array of claim 5 wherein at least 50% of the probes comprise at least two CG dinucleotides. 7. The array of claim 5 wherein at least 20% of the probes comprise at least three CG dinucleotides. 8. A method of selecting probes to be included in an array of probes comprising: identifying a plurality of CpG islands wherein said plurality comprises more than 10,000 different CpG islands in the genome of a single organism, wherein a CpG island is a genomic region that is at least 200 bases in length and has a GC content of at least 50%; defining the ends of each CpG island and thereby identifying a probe selection region for each CpG island in the plurality; and selecting a probe set for each probe selection region, wherein each probe set comprises at least 2 probes that are perfectly complementary to the probe selection region targeted by that probe set. 9. The method of claim 8 further comprising identifying a plurality of genes in said organism that are regulated by methylation and selecting a probe set for each of said genes, wherein each probe set comprises at least 2 probes that are perfectly complementary to the gene targeted by the probe set. 10. The method of claim 8 wherein the organism is human and the plurality comprises more than 25,000 CpG islands. 11. The method of claim 10 wherein each CpG island is targeted by a probe set comprising at least 4 perfect match probes. 12. The method of claim 8 wherein the organism is mouse. 13. The method of claim 8 wherein the organism is rat.

Assignees

Inventors

Classifications

  • C12Q1/6837Primary

    using probe arrays or probe chips (C12Q1/6874 takes precedence) · CPC title

  • C12Q1/6883Primary

    for diseases caused by alterations of genetic material · CPC title

  • Methylation markers · CPC title

  • Bisulfite(s) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10822659B2 cover?
Arrays for genome-wide analysis of methylation are disclosed. In a preferred aspect arrays comprising a plurality of probes complementary to a plurality of identified CpG islands in the human, mouse and rat genome are disclosed. The arrays may be used to detect methylation within CpG islands in samples from human, mouse and rat genomes.
Who is the assignee on this patent?
Affymetrix Inc
What technology area does this patent fall under?
Primary CPC classification C12Q1/6837. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).